Additional use of Abeta42/Abeta40 ratio with cerebrospinal fluid biomarkers P-Tau and Abeta42 increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice

Manuscript Number: 

13-1838R1

Author(s): 
Guerric DidierLaurent, Marie-Christine Escanye, Clotilde Latarche, Catherine Malaplate-Armand, Jean-Luc Olivier, Mathilde Sauvée

Disclosures

Guerric DidierLaurent

  • Nothing to Disclose

Marie-Christine Escanye

  • Nothing to Disclose

Clotilde Latarche

  • Nothing to Disclose

Catherine Malaplate-Armand

  • Nothing to Disclose

Jean-Luc Olivier

  • Nothing to Disclose

Mathilde Sauvée

  • Lecture Fees:
    twice to speak about SPECT and dementia with neurologists local speaking